Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-06 11:36 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
57,766 | $0 | $0 | 0 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-16 08:48 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
3,762 | $8.34 | $31,375 | 173,061 (Direct) |
View |
| 2023-01-30 Sale |
2023-01-31 08:28 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
10,106 | $8.35 | $84,385 | 176,823 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-09 4:13 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
2,893 | $7.25 | $20,974 | 186,929 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-16 08:01 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
3,762 | $3.09 | $11,625 | 189,822 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 4:17 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
2,894 | $3.19 | $9,232 | 83,084 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-17 4:02 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
8,086 | $3.28 | $26,522 | 85,978 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 9:27 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
3,763 | $7.32 | $27,545 | 94,064 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 5:44 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
4,354 | $10.37 | $45,151 | 76,127 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer |
257,500 | $0 | 257,500 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-01 5:04 pm |
N/A 2034-09-29 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:30 pm |
N/A 2034-06-12 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-03-06 Equity Swap |
2023-03-06 11:36 am |
N/A N/A |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
80,595 | $0 | 0 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:52 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 4:38 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 4:03 pm |
N/A N/A |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
110,500 | $0 | 193,584 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:01 pm |
N/A 2031-06-15 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-01-05 Option Award |
2021-01-07 4:35 pm |
N/A 2031-01-04 |
CONCERT PHARMACEUTICALS INC. | CNCE | Cassella James V Chief Development Officer |
82,100 | $0 | 158,227 (Direct) |
View |